Oracle (NYSE:ORCL) Price Target Increased to $120.00 by Analysts at JPMorgan Chase & Co.

Oracle (NYSE:ORCL) had its target price increased by analysts at JPMorgan Chase & Co. from $110.00 to $120.00 in a research note issued to investors on Monday. JPMorgan Chase & Co.‘s price objective points to a potential downside of 14.65% from the stock’s current price.

ORCL has been the subject of several other research reports. TD Cowen increased their price objective on shares of Oracle from $145.00 to $165.00 and gave the company a “buy” rating in a research report on Wednesday, June 12th. Morgan Stanley reiterated an “equal weight” rating and issued a $125.00 price target on shares of Oracle in a research report on Tuesday, June 25th. JMP Securities restated a “market perform” rating on shares of Oracle in a research report on Tuesday, June 11th. Deutsche Bank Aktiengesellschaft lifted their target price on Oracle from $150.00 to $165.00 and gave the stock a “buy” rating in a report on Monday, June 17th. Finally, Stifel Nicolaus increased their price target on Oracle from $120.00 to $135.00 and gave the company a “hold” rating in a report on Wednesday, June 12th. Fourteen equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $146.30.

Oracle Price Performance

Shares of ORCL traded down $1.22 during mid-day trading on Monday, reaching $140.59. The stock had a trading volume of 11,301,670 shares, compared to its average volume of 8,075,473. The business has a fifty day moving average of $138.72 and a 200 day moving average of $128.62. The company has a debt-to-equity ratio of 8.25, a quick ratio of 0.72 and a current ratio of 0.71. The firm has a market cap of $387.45 billion, a price-to-earnings ratio of 38.11, a PEG ratio of 2.56 and a beta of 1.01. Oracle has a 12 month low of $99.26 and a 12 month high of $146.59.

Oracle (NYSE:ORCL) last released its earnings results on Tuesday, June 11th. The enterprise software provider reported $1.63 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.65 by ($0.02). Oracle had a return on equity of 223.01% and a net margin of 19.76%. The business had revenue of $14.29 billion for the quarter, compared to analysts’ expectations of $14.57 billion. During the same quarter in the prior year, the business posted $1.35 EPS. The business’s revenue for the quarter was up 3.3% compared to the same quarter last year. Equities analysts predict that Oracle will post 5.02 EPS for the current year.

Insider Activity

In other Oracle news, Chairman Lawrence Joseph Ellison sold 1,125,000 shares of Oracle stock in a transaction dated Monday, July 15th. The stock was sold at an average price of $143.69, for a total transaction of $161,651,250.00. Following the completion of the transaction, the chairman now owns 1,145,732,353 shares in the company, valued at approximately $164,630,281,802.57. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Jeffrey Berg sold 22,500 shares of the firm’s stock in a transaction on Thursday, June 20th. The shares were sold at an average price of $143.12, for a total transaction of $3,220,200.00. Following the sale, the director now owns 210,712 shares in the company, valued at $30,157,101.44. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Chairman Lawrence Joseph Ellison sold 1,125,000 shares of the company’s stock in a transaction dated Monday, July 15th. The stock was sold at an average price of $143.69, for a total transaction of $161,651,250.00. Following the completion of the transaction, the chairman now owns 1,145,732,353 shares of the company’s stock, valued at approximately $164,630,281,802.57. The disclosure for this sale can be found here. Insiders have sold 1,862,500 shares of company stock valued at $266,776,624 in the last ninety days. Insiders own 42.80% of the company’s stock.

Institutional Investors Weigh In On Oracle

A number of institutional investors have recently added to or reduced their stakes in ORCL. International Assets Investment Management LLC raised its stake in Oracle by 153.3% in the 4th quarter. International Assets Investment Management LLC now owns 11,947 shares of the enterprise software provider’s stock valued at $1,260,000 after purchasing an additional 7,230 shares during the last quarter. Brio Consultants LLC lifted its stake in shares of Oracle by 4.1% in the fourth quarter. Brio Consultants LLC now owns 2,942 shares of the enterprise software provider’s stock worth $310,000 after buying an additional 117 shares in the last quarter. Precision Wealth Strategies LLC boosted its position in Oracle by 4.1% during the fourth quarter. Precision Wealth Strategies LLC now owns 3,951 shares of the enterprise software provider’s stock worth $417,000 after acquiring an additional 155 shares during the last quarter. Gilbert & Cook Inc. purchased a new stake in Oracle during the 4th quarter valued at about $359,000. Finally, Aveo Capital Partners LLC acquired a new stake in Oracle in the 4th quarter valued at about $290,000. Institutional investors and hedge funds own 42.44% of the company’s stock.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.